CPAP APAP denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on CPAP APAP
## Why BCBS May Apply Step-Therapy Logic to CPAP/APAP
Although step therapy is most commonly associated with pharmaceuticals, some BCBS plans apply a similar "conservative-treatment-first" requirement to PAP therapy for sleep apnea. The plan may require documentation that certain behavioral or positional interventions were attempted — or were clinically contraindicated — before approving a PAP device. A step-therapy denial for CPAP/APAP typically indicates the plan's reviewer believed the record did not show that a required prior step was completed or adequately documented.
This denial is highly appealable. For most patients with moderate-to-severe obstructive sleep apnea, PAP therapy is the recognized first-line intervention, and the applicable sleep-medicine guideline organizations support this position. The appeal strategy is to demonstrate either that the required prior steps were completed (with documented outcomes) or that they were clinically inappropriate for your specific presentation.
## Federal Appeal Rights
- ERISA §503 (self-funded employer plans): full-and-fair internal review with written denial reasons.
- ACA §2719 (fully insured plans): independent external review by an accredited IRO after internal exhaustion.
- External-review window: approximately four months from the internal-denial notice — confirm the exact date on your denial letter.
- Expedited review: if your health would be seriously jeopardized by delay, request expedited processing at the same time you file the internal appeal.
- Step-therapy override laws: many states have enacted step-therapy override legislation requiring plans to grant exceptions when the required prior therapy is contraindicated, previously failed, or not in the patient's best interest. Check whether your state's law applies.
## Concrete Appeal Process
1. Obtain the denial notice identifying the specific prior-step requirement and the policy language cited. 2. Request BCBS's current step-therapy or coverage criteria for CPAP/APAP. 3. Determine which step was deemed incomplete and gather evidence that it was completed or is clinically inappropriate. 4. File the internal appeal with documentation and your treating physician's letter. 5. Escalate to external review if the internal appeal is denied, citing applicable sleep-medicine guidelines.
## Documentation to Gather
- Diagnostic sleep study: full report confirming diagnosis and clinical severity, establishing the clinical basis for going directly to PAP therapy.
- Prior-step history: chart notes, dates, and outcomes for any behavioral, positional, or other conservative interventions that were tried before PAP.
- Clinical exception documentation: if a prior step was not appropriate for your case (e.g., positional therapy not viable given severity), the prescriber's written clinical reasoning.
- Guideline-organization citation: a reference in the prescriber's letter to the relevant sleep-medicine guideline body's recommendation for first-line PAP therapy in patients with your severity of disease.
- Prescriber medical-necessity letter: explicitly addressing each step in the BCBS criteria and explaining why your case satisfies or is exempt from each requirement.
## Criteria-Mapping Structure
For each step in BCBS's pathway, document completion or exception:
| BCBS Step-Therapy Requirement | Completion or Exception Evidence | |---|---| | Prior conservative treatment attempted | Chart notes with dates and documented outcomes | | Conservative treatment failed or is inappropriate | Prescriber letter with clinical rationale | | Sleep-study severity supports PAP as appropriate next step | Severity finding from sleep-study report | | Prescriber attestation of medical necessity | Signed medical-necessity letter |
Cite the applicable guideline organization generically (e.g., "consistent with American Academy of Sleep Medicine guidance") without reproducing specific numeric thresholds — the prescriber's letter should make that clinical connection explicitly.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus